Baxter International Inc (BAX) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.096x

Based on the latest financial reports, Baxter International Inc (BAX) has a cash flow conversion efficiency ratio of 0.096x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($584.00 Million) by net assets ($6.10 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Baxter International Inc - Cash Flow Conversion Efficiency Trend (1985–2025)

This chart illustrates how Baxter International Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Baxter International Inc for a breakdown of total debt and financial obligations.

Baxter International Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Baxter International Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Securitas AB
ST:SECU-B
0.095x
Littelfuse Inc
NASDAQ:LFUS
0.057x
Sibanye Stillwater Limited
F:47VS
0.096x
MISC Bhd
KLSE:3816
0.038x
MARKS SPENCER ADR LS-25
F:MA6A
N/A
Hebei Sinopack Electronic Technolog
SHE:003031
0.043x
CAVA Group, Inc.
NYSE:CAVA
0.052x
Chongqing Rural Commercial Bank Co
SHG:601077
0.054x

Annual Cash Flow Conversion Efficiency for Baxter International Inc (1985–2025)

The table below shows the annual cash flow conversion efficiency of Baxter International Inc from 1985 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Baxter International Inc.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $6.10 Billion $845.00 Million 0.138x -4.55%
2024-12-31 $7.02 Billion $1.02 Billion 0.145x -28.82%
2023-12-31 $8.47 Billion $1.73 Billion 0.204x -0.78%
2022-12-31 $5.89 Billion $1.21 Billion 0.205x -15.67%
2021-12-31 $9.12 Billion $2.22 Billion 0.244x +13.80%
2020-12-31 $8.73 Billion $1.87 Billion 0.214x -19.50%
2019-12-31 $7.91 Billion $2.10 Billion 0.266x +3.71%
2018-12-31 $7.87 Billion $2.02 Billion 0.256x +36.38%
2017-12-31 $9.12 Billion $1.71 Billion 0.188x -5.88%
2016-12-31 $8.28 Billion $1.65 Billion 0.200x -0.01%
2015-12-31 $8.87 Billion $1.77 Billion 0.200x -49.32%
2014-12-31 $8.16 Billion $3.21 Billion 0.394x +4.60%
2013-12-31 $8.49 Billion $3.20 Billion 0.377x -15.33%
2012-12-31 $6.98 Billion $3.11 Billion 0.445x +7.89%
2011-12-31 $6.83 Billion $2.82 Billion 0.413x -6.63%
2010-12-31 $6.80 Billion $3.00 Billion 0.442x +12.71%
2009-12-31 $7.42 Billion $2.91 Billion 0.392x -2.90%
2008-12-31 $6.23 Billion $2.52 Billion 0.404x +21.14%
2007-12-31 $6.92 Billion $2.31 Billion 0.333x -4.24%
2006-12-31 $6.27 Billion $2.18 Billion 0.348x -3.47%
2005-12-31 $4.30 Billion $1.55 Billion 0.361x -3.20%
2004-12-31 $3.71 Billion $1.38 Billion 0.372x -14.42%
2003-12-31 $3.27 Billion $1.43 Billion 0.435x +7.22%
2002-12-31 $2.94 Billion $1.19 Billion 0.406x +40.43%
2001-12-31 $3.76 Billion $1.09 Billion 0.289x -34.64%
2000-12-31 $2.66 Billion $1.18 Billion 0.442x +36.72%
1999-12-31 $3.35 Billion $1.08 Billion 0.323x -2.20%
1998-12-31 $2.84 Billion $939.00 Million 0.331x +55.24%
1997-12-31 $2.62 Billion $558.00 Million 0.213x -32.72%
1996-12-31 $2.50 Billion $793.00 Million 0.317x -12.20%
1995-12-31 $3.70 Billion $1.34 Billion 0.361x +1.96%
1994-12-31 $3.72 Billion $1.32 Billion 0.354x +47.29%
1993-12-31 $3.19 Billion $765.00 Million 0.240x +19.46%
1992-12-31 $3.79 Billion $763.00 Million 0.201x +14.33%
1991-12-31 $4.37 Billion $769.00 Million 0.176x -9.60%
1990-12-31 $4.09 Billion $796.00 Million 0.195x +33.65%
1989-12-31 $4.25 Billion $618.00 Million 0.146x -34.55%
1985-12-31 $2.08 Billion $463.00 Million 0.222x --

About Baxter International Inc

NYSE:BAX USA Medical Instruments & Supplies
Market Cap
$9.26 Billion
Market Cap Rank
#2389 Global
#840 in USA
Share Price
$17.99
Change (1 day)
+2.86%
52-Week Range
$15.80 - $31.88
All Time High
$85.36
About

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable p… Read more